Literature DB >> 18551196

Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome.

Ahmad S Amin1, Lucas J Herfst, Brian P Delisle, Christine A Klemens, Martin B Rook, Connie R Bezzina, Heather A S Underkofler, Katherine M Holzem, Jan M Ruijter, Hanno L Tan, Craig T January, Arthur A M Wilde.   

Abstract

Type 2 congenital long QT syndrome (LQT-2) is linked to mutations in the human ether a-go-go-related gene (HERG) and is characterized by rate-corrected QT interval (QTc) prolongation, ventricular arrhythmias, syncope, and sudden death. Recognized triggers of these cardiac events include emotional and acoustic stimuli. Here we investigated the repeated occurrence of fever-induced polymorphic ventricular tachycardia and ventricular fibrillation in 2 LQT-2 patients with A558P missense mutation in HERG. ECG analysis showed increased QTc with fever in both patients. WT, A558P, and WT+A558P HERG were expressed heterologously in HEK293 cells and were studied using biochemical and electrophysiological techniques. A558P proteins showed a trafficking-deficient phenotype. WT+A558P coexpression caused a dominant-negative effect, selectively accelerated the rate of channel inactivation, and reduced the temperature-dependent increase in the WT current. Thus, the WT+A558P current did not increase to the same extent as the WT current, leading to larger current density differences at higher temperatures. A similar temperature-dependent phenotype was seen for coexpression of the trafficking-deficient LQT-2 F640V mutation. We postulate that the weak increase in the HERG current density in WT-mutant coassembled channels contributes to the development of QTc prolongation and arrhythmias at febrile temperatures and suggest that fever is a potential trigger of life-threatening arrhythmias in LQT-2 patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551196      PMCID: PMC2423868          DOI: 10.1172/JCI35337

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.

Authors:  R J Jongbloed; A A Wilde; J L Geelen; P Doevendans; C Schaap; I Van Langen; J P van Tintelen; J M Cobben; G C Beaufort-Krol; J P Geraedts; H J Smeets
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

2.  Estimation of potency of HERG channel blockers: impact of voltage protocol and temperature.

Authors:  Jian-An Yao; Xiaoyi Du; Daniel Lu; Robert L Baker; Eric Daharsh; Philip Atterson
Journal:  J Pharmacol Toxicol Methods       Date:  2005 Jul-Aug       Impact factor: 1.950

Review 3.  Concepts of fever.

Authors:  P A Mackowiak
Journal:  Arch Intern Med       Date:  1998-09-28

4.  Long-term (subacute) potassium treatment in congenital HERG-related long QT syndrome (LQTS2).

Authors:  H L Tan; M Alings; R W Van Olden; A A Wilde
Journal:  J Cardiovasc Electrophysiol       Date:  1999-02

5.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Authors:  David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

6.  Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia.

Authors:  M C Sanguinetti; M E Curran; P S Spector; M T Keating
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

7.  Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.

Authors:  A S Amin; A O Verkerk; Z A Bhuiyan; A A M Wilde; H L Tan
Journal:  Acta Physiol Scand       Date:  2005-12

Review 8.  Brugada syndrome: report of the second consensus conference.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Heart Rhythm       Date:  2005-04       Impact factor: 6.343

9.  Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1).

Authors:  A A Wilde; R J Jongbloed; P A Doevendans; D R Düren; R N Hauer; I M van Langen; J P van Tintelen; H J Smeets; H Meyer; J L Geelen
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

10.  Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization.

Authors:  J Zeng; K R Laurita; D S Rosenbaum; Y Rudy
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

View more
  35 in total

1.  Electrophysiological study of V535M hERG mutation of LQT2.

Authors:  Chunyan Shao; Yan Lu; Mohan Liu; Qi Chen; Yunfeng Lan; Yan Liu; Min Lin; Yang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

Review 2.  HERG1 channelopathies.

Authors:  Michael C Sanguinetti
Journal:  Pflugers Arch       Date:  2009-11-22       Impact factor: 3.657

3.  Acquired QT interval prolongation and ventricular arythmias associated with brucellosis: A case report and review of literature.

Authors:  Atakan Yanikoglu; Ibrahim Basarici; Emre Altekin; Serkan Karakas; Sinan Ozbek; Ali R Gulcan; Cengiz Ermis
Journal:  J Cardiol Cases       Date:  2011-07-23

Review 4.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

5.  Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Amanda L Vega; David J Tester; Michael J Ackerman; Jonathan C Makielski
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08-25

6.  Effects of Temperature on Heteromeric Kv11.1a/1b and Kv11.3 Channels.

Authors:  Maike Mauerhöfer; Christiane K Bauer
Journal:  Biophys J       Date:  2016-08-09       Impact factor: 4.033

7.  Impact of dosing regimen of custirsen, an antisense oligonucleotide, on safety, tolerability and cardiac repolarization in healthy subjects.

Authors:  Laura Rabinovich-Guilatt; Anna Elgart; Lavi Erisson; Sandra K Willsie; Shoshi Tessler; Ofra Barnett-Griness; Amitkumar Pande; Ofer Spiegelstein
Journal:  Br J Clin Pharmacol       Date:  2015-06-22       Impact factor: 4.335

8.  Ventricular repolarization lability in children with Kawasaki disease.

Authors:  Marina Kuriki; Masayuki Fujino; Ken-ichi Tanaka; Kayo Horio; Hirofumi Kusuki; Misa Hosoi; Yoshihiko Eryu; Tomochika Kato; Toshio Yamazaki; Tadayoshi Hata
Journal:  Pediatr Cardiol       Date:  2011-02-23       Impact factor: 1.655

9.  Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome.

Authors:  A S Amin; C A Klemens; A O Verkerk; P G Meregalli; A Asghari-Roodsari; J M T de Bakker; C T January; A A M Wilde; H L Tan
Journal:  Neth Heart J       Date:  2010-03       Impact factor: 2.380

10.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  Heart Rhythm       Date:  2020-10-19       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.